{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T21:23:43Z","timestamp":1787261023291,"version":"build-2736575974"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ctro.2026.101191","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T02:31:15Z","timestamp":1779676275000},"page":"101191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Safety and early organ preservation outcomes after dose escalation with MR-guided radiotherapy for rectal cancer (preRADAR): A phase I trial"],"prefix":"10.1016","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3645-2530","authenticated-orcid":false,"given":"H.","family":"Eijkelenkamp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4966-3502","authenticated-orcid":false,"given":"M.E.","family":"Verweij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Grimbergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.M.","family":"Kensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Vijlbrief","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.M.U.","family":"van Grevenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6913-9954","authenticated-orcid":false,"given":"L.M.G.","family":"Moons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Koopman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.M.","family":"Lacle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6580-4331","authenticated-orcid":false,"given":"M.N.G.J.A.","family":"Braat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7721-2341","authenticated-orcid":false,"given":"M.","family":"Maas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.C.J.","family":"Consten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9777-7921","authenticated-orcid":false,"given":"A.","family":"Pronk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.B.","family":"Smits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0063-1705","authenticated-orcid":false,"given":"J.T.","family":"Heikens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.G.","family":"Elias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.M.","family":"Verkooijen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7275-319X","authenticated-orcid":false,"given":"G.J.","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3547-1895","authenticated-orcid":false,"given":"A.","family":"Couwenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5068-5517","authenticated-orcid":false,"given":"M.P.W.","family":"Intven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2026.101191_b0005","first-page":"281","article-title":"Laparoscopic total mesorectal excision (TME) for rectal cancer surgery: long-term outcomes","volume":"18","author":"Leroy","year":"2004","journal-title":"Surg Endosc Other Interv Tech"},{"key":"10.1016\/j.ctro.2026.101191_b0010","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/SLA.0b013e3181dae4ed","article-title":"Postoperative complications following surgery for rectal cancer","volume":"251","author":"Paun","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.ctro.2026.101191_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/SLA.0000000000005523","article-title":"Morbidity, Mortality, and Pathologic Outcomes of Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer Short-term Outcomes from a Multicenter Randomized Controlled Trial","volume":"277","author":"Liu","year":"2023","journal-title":"Ann Surg"},{"key":"10.1016\/j.ctro.2026.101191_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2025.05.528","article-title":"Localised rectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","author":"Hofheinz","year":"2025","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctro.2026.101191_b0025","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.619852","article-title":"MR-Guided Radiotherapy for Rectal Cancer: Current Perspective on Organ Preservation","volume":"11","author":"Boldrini","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.ctro.2026.101191_b0030","first-page":"9","article-title":"Organ preservation in rectal cancer \u2013 challenges and future strategies","volume":"3","author":"Gani","year":"2017","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101191_b0035","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1200\/JCO.22.00032","article-title":"Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy","volume":"40","author":"Garcia-Aguilar","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctro.2026.101191_b0040","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/s41571-021-00538-5","article-title":"International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer","volume":"18","author":"Fokas","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ctro.2026.101191_b0045","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1200\/JCO.21.02708","article-title":"Practical Considerations in Diagnosing and Managing Early-Onset GI Cancers","volume":"40","author":"Lumish","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctro.2026.101191_b0050","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.6004\/jnccn.2022.7056","article-title":"Diagnosis and management of rectal cancer in patients younger than 50 years: rising global incidence and unique challenges","volume":"20","author":"Lang","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.ctro.2026.101191_b0055","first-page":"233","article-title":"Colorectal cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ctro.2026.101191_b0060","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/S0140-6736(18)31078-X","article-title":"Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study","volume":"391","author":"van der Valk","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ctro.2026.101191_b0065","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1200\/JCO.23.01208","article-title":"Long-term results of organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy: the randomized phase II OPRA Trial","volume":"42","author":"Verheij","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctro.2026.101191_b0070","doi-asserted-by":"crossref","DOI":"10.1093\/bjsopen\/zrab137","article-title":"Radiotherapy regimens for rectal cancer: long-term outcomes and health-related quality of life in the Stockholm III trial","volume":"5","author":"Erlandsson","year":"2021","journal-title":"BJS Open"},{"key":"10.1016\/j.ctro.2026.101191_b0075","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/bjs.9811","article-title":"Tumour regression in the randomized Stockholm III Trial of radiotherapy regimens for rectal cancer","volume":"102","author":"Pettersson","year":"2015","journal-title":"Br J Surg"},{"key":"10.1016\/j.ctro.2026.101191_b0080","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S1470-2045(17)30086-4","article-title":"Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial","volume":"18","author":"Erlandsson","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctro.2026.101191_b0085","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ijrobp.2012.05.017","article-title":"Radiation dose-response model for locally advanced rectal cancer after preoperative chemoradiation therapy","volume":"85","author":"Appelt","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101191_b0090","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.ijrobp.2020.06.013","article-title":"Efficacy of dose-escalated chemoradiation on complete tumor response in patients with locally advanced rectal cancer (RECTAL-BOOST): a phase 2 randomized controlled trial","volume":"108","author":"Couwenberg","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101191_b0095","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.annonc.2024.10.827","article-title":"A phase III randomised trial on the addition of a contact X-ray brachytherapy boost to standard neoadjuvant chemo-radiotherapy for organ preservation in early rectal adenocarcinoma: 5 year results of the OPERA trial","volume":"36","author":"Baron","year":"2025","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctro.2026.101191_b0100","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-065010","article-title":"Towards Response ADAptive Radiotherapy for organ preservation for intermediate-risk rectal cancer (preRADAR): protocol of a phase I dose-escalation trial","volume":"13","author":"Verweij","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.ctro.2026.101191_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2021.07.011","article-title":"Planning target volume margin assessment for online adaptive MR-guided dose-escalation in rectal cancer on a 1.5 T MR-Linac","volume":"162","author":"Eijkelenkamp","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101191_b0110","first-page":"153","article-title":"Online MR guided dose escalated radiotherapy for organ preservation in distal rectal cancer","volume":"37","author":"Boeke","year":"2022","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101191_b0115","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.radonc.2021.09.002","article-title":"A novel approach for radiotherapy dose escalation in rectal cancer using online MR-guidance and rectal ultrasound gel filling \u2013 Rationale and first in human","volume":"164","author":"Gani","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101191_b0120","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.radonc.2020.09.024","article-title":"Online adaptive MR-guided radiotherapy for rectal cancer; feasibility of the workflow on a 1.5T MR-linac: clinical implementation and initial experience","volume":"154","author":"Intven","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101191_b0125","article-title":"Quality of life and clinical outcomes in rectal cancer patients treated on a 1.5T MR-Linac within the MOMENTUM study. Clin Transl","volume":"45","author":"Daamen","year":"2024","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101191_b0130","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fonc.2017.00059","article-title":"R-IDEAL: a framework for systematic clinical evaluation of technical innovations in radiation oncology","volume":"7","author":"Verkooijen","year":"2017","journal-title":"Front Oncol"},{"key":"10.1016\/j.ctro.2026.101191_b0135","doi-asserted-by":"crossref","unstructured":"Verweij ME, Hoendervangers S, von Hebel CM, Pronk A, W Schiphorst AH, J Consten EC, et al. Patient-and physician-reported radiation-induced toxicity of short-course radiotherapy with a prolonged interval to surgery for rectal cancer 2022. https:\/\/doi.org\/10.1111\/codi.16315.","DOI":"10.1016\/S0167-8140(22)02864-X"},{"key":"10.1016\/j.ctro.2026.101191_b0140","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.radonc.2020.03.011","article-title":"Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer \u2013 results of the international randomized RAPIDO-trial","volume":"147","author":"van der Valk","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101191_b0145","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1200\/JCO.21.01667","article-title":"Multicenter, Randomized, phase III Trial of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy in locally Advanced Rectal Cancer (STELLAR)","volume":"40","author":"Jin","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctro.2026.101191_b0150","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.annonc.2024.06.019","article-title":"Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial","volume":"35","author":"Conroy","year":"2024","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctro.2026.101191_b0155","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2025-111711","volume":"15","author":"De Vries","year":"2025","journal-title":"BMJ Open"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826000868?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826000868?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T20:25:52Z","timestamp":1787257552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630826000868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":31,"alternative-id":["S2405630826000868"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101191","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and early organ preservation outcomes after dose escalation with MR-guided radiotherapy for rectal cancer (preRADAR): A phase I trial","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101191","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101191"}}